Jyrki Berg

Blog March 2, 2025 The Deadly Impact of Counterfeit Diabetes Medications For the 500+ million people living with diabetes worldwide, proper management of the disease is non-negotiable. From insulin injections to oral medications, these treatments are critical to maintaining blood sugar... → Blog February 17, 2025 How Counterfeit Medications Target Developing Countries The proliferation of counterfeit medications poses a global health crisis, disproportionately affecting developing countries. These regions, often grappling with weak regulatory frameworks, limited healthcare access, and financial constraints, have become... → Blog February 11, 2025 How Counterfeit Medications Undermine Pharmaceutical Innovation The global pharmaceutical industry is built on a foundation of research, innovation, and trust. However, the growing threat of counterfeit medications not only endangers patient safety but also undermines the... → Blog February 5, 2025 Europol’s Stark Warning on Pharmaceutical Crime—and What We Must Do Next Europol’s latest report, The Threat of Pharmaceutical Crime in the EU and Beyond, exposes an alarming reality: counterfeit medicines are infiltrating the global supply chain, endangering lives, and fueling organized... → Blog January 29, 2025 From Production to Patient: How Pharmaceutical Counterfeits Enter the Supply Chain The pharmaceutical supply chain is a cornerstone of global healthcare, providing life-saving medications to billions of people. However, counterfeit drugs pose a significant threat to patient safety, public health, and... →